Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 126325-46-0 | MDL No. : | MFCD03095215 |
Formula : | C6H7BrN2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | JYWWGZAAXTYNRN-UHFFFAOYSA-N |
M.W : | 187.04 | Pubchem ID : | 2734416 |
Synonyms : |
|
Num. heavy atoms : | 9 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.17 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 41.31 |
TPSA : | 38.91 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.3 cm/s |
Log Po/w (iLOGP) : | 1.89 |
Log Po/w (XLOGP3) : | 1.6 |
Log Po/w (WLOGP) : | 1.74 |
Log Po/w (MLOGP) : | 1.33 |
Log Po/w (SILICOS-IT) : | 1.78 |
Consensus Log Po/w : | 1.67 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.5 |
Solubility : | 0.59 mg/ml ; 0.00316 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.03 |
Solubility : | 1.75 mg/ml ; 0.00936 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.91 |
Solubility : | 0.232 mg/ml ; 0.00124 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.48 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302+H312+H332-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
55% | With sulfuric acid; bromine In (2S)-N-methyl-1-phenylpropan-2-amine hydrate; water | Step 1 Preparation of 6-amino-5-bromo-picoline 32.4 g (0.3 mole) of 6-aminopicoline was dissolved in a mixture of 28 g of conc. sulfuric acid and 120 ml of water and the resulting solution was cooled in ice water. 52.8 g (0.33 mole) of bromine was added dropwise to the solution over 30 minutes at 0° C. The reaction solution was stirred for 20 minutes at room temperature and neutralized with cold aqueous NaOH solution. The resultant was filtered and the solid was purified with column chromatography using methylene chloride and ethyl acetate as an eluent to obtain 31 g of the title compound (yield 55percent). |
[ 91872-10-5 ]
3,5-Dibromo-6-methyl-2-pyridinamine
Similarity: 0.88
[ 1805028-09-4 ]
3-Bromo-6-(difluoromethyl)pyridin-2-amine
Similarity: 0.84
[ 524718-27-2 ]
4-Bromo-6-methylpyridin-2-amine
Similarity: 0.82
[ 91872-10-5 ]
3,5-Dibromo-6-methyl-2-pyridinamine
Similarity: 0.88
[ 1805028-09-4 ]
3-Bromo-6-(difluoromethyl)pyridin-2-amine
Similarity: 0.84
[ 524718-27-2 ]
4-Bromo-6-methylpyridin-2-amine
Similarity: 0.82
[ 91872-10-5 ]
3,5-Dibromo-6-methyl-2-pyridinamine
Similarity: 0.88
[ 1805028-09-4 ]
3-Bromo-6-(difluoromethyl)pyridin-2-amine
Similarity: 0.84
[ 524718-27-2 ]
4-Bromo-6-methylpyridin-2-amine
Similarity: 0.82